Policy & Global Development

COVID-19 and the Reform of the Biomedical R&D System: A Proposal for a Preferred Supplier Model

An ISGlobal Discussion Paper

June 2021

Discussion paper that addresses the need for a reformed pharmaceutical R&D system, the R&D investments and response in the fight against COVID-19, and the Preferred Supplier Model, as an alternative based on the public sector’s leverage.

Published in June 2021, the document is part of the #ISGlobal_debate series. It is signed by Adrián Alonso, Marina Espriu, Joan Bigorra, Rafael Vilasanjuan and Gonzalo Fanjul, who aknowledge the valuable contributions by Elena Villanueva.